How do I find clinical trials in the UK?

Use TrialConnect to search by condition, location, or eligibility. We index over 29,000 UK clinical trials from ClinicalTrials.gov, updated daily. Enter your condition and we show matching trials near you.

Are there paid clinical trials in the UK?

Yes. Healthy volunteers can earn £500–£3,000 for Phase 1 and bioequivalence studies. TrialConnect lists paid research studies at UK research units in London, Leeds, Nottingham, and more.

What conditions have clinical trials available?

TrialConnect covers 41 conditions including breast cancer, lung cancer, diabetes, heart failure, COPD, multiple sclerosis, Parkinson's disease, Crohn's disease, and many more.

Is TrialConnect free?

Yes. TrialConnect is completely free for patients. We are not affiliated with the NHS or NIHR. Data is sourced from ClinicalTrials.gov.

Am I eligible for a clinical trial?

Each trial has specific eligibility criteria including age, condition, medical history, and current treatments. TrialConnect shows you trials that may match your situation, but only the trial team can confirm eligibility.

The Effectiveness of a Herbal Supplement in Osteoarthritis.

View on ClinicalTrials.gov ↗

At a glance

What the study gets you: Access to the study treatment being tested
Type of study: Interventional (receives a drug or procedure)
Time in hospital: In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention: Active treatment (supplement), Placebo (other)
How long the study runs: Study runs about 9 months (dates as stated)
About the drug or intervention: Active treatment — supplement: A dietary supplement containing standardised herbal extracts of Boswellia serrata (525 mg), Curcuma longa (150 mg), Vitis vinifera (75 mg). · Placebo — other: A placebo containing no standardised herbal extracts or other active ingredients.
Patient visit burden: Not specified by the sponsor

Type of study: Testing a treatment
Ages: 18 Years and over
Who: All
Number of participants: 30
Started: 2025-12-05
Last checked: 2025-06

Plain English Summary

What is this study?

• Testing a new treatment for osteoarthritis (oa)
• NA - 30 participants
• This study aims to evaluate the effectiveness and safety of a combined herbal supplement containing Boswellia serrata, Curcuma longa, and Vitis vinifera in adults with clinically diagnosed knee or hip osteoarthritis

Who can take part?

• Ages 18 Years and over
• Diagnosed with osteoarthritis (oa)

Where?

• London - Middlesex Univeristy London

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

This study aims to evaluate the effectiveness and safety of a combined herbal supplement containing Boswellia serrata, Curcuma longa, and Vitis vinifera in adults with clinically diagnosed knee or hip osteoarthritis. The primary objective is to determine whether the supplement improves osteoarthritis-related symptoms. The supplement will be compared with a placebo. Participants will: * take the supplement and placebo for 4 weeks each, one at a time; * complete validated questionnaires (6 times online) * perform three performance-based physical tests (6 times online) * provide a urine sample

Osteoarthritis (OA)Osteoarthritis (OA) of the HipOsteoarthritis (OA) of the KneeOsteoarthritis

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search

Age· Tell us your age for better matching

Gender· Tell us your sex for better matching

Still need:

• Tell us your age for better matching
• Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

Age: 18 Years and over
Who can join: All genders

What the study is looking for

✓Aged ≥ 18
✓Diagnosis of osteoarthritis in knee or hip
✓Numerical Rating Scale (NRS) ≥ 4 during the most painful movement in the last 24 hours
✓Lequesne's Functional Index (LFI) score ≥ 7
✓Ambulant patient

Who cannot take part

✗Pregnant and breastfeeding
✗Autoimmune disease such as rheumatoid arthritis, gout, lupus
✗Joint trauma, joint injury, joint infection, meniscus tear, complete loss of articular cartilage
✗Expectation of surgery
✗History of the viscous or corticosteroids injections into affected joints or oral corticosteroids within last 12 months

See the full criteria

Inclusion Criteria: * Aged ≥ 18 * Diagnosis of osteoarthritis in knee or hip * Numerical Rating Scale (NRS) ≥ 4 during the most painful movement in the last 24 hours * Lequesne's Functional Index (LFI) score ≥ 7 * Ambulant patient Exclusion Criteria: * Pregnant and breastfeeding * Autoimmune disease such as rheumatoid arthritis, gout, lupus * Joint trauma, joint injury, joint infection, meniscus tear, complete loss of articular cartilage * Expectation of surgery * History of the viscous or corticosteroids injections into affected joints or oral corticosteroids within last 12 months * Allergy to one of the intervention's ingredients or NSAIDs * Peptic ulceration and upper gastrointestinal haemorrhage * High alcohol intake, inability to abstain from alcohol, substance abuse, history of addiction * Tumor, cancer * Abnormal renal or/and hepatic functions or altered blood chemistry * Use of concomitant medication able to interfere with the interventions

Where Is This Study? (1 UK site)

Middlesex Univeristy London

London NW4 4BT, United Kingdom

Recruiting

Site contact (verified)

Patrycja Brodka Pedro, MScPrincipal Investigator

Patrycja Brodka Pedro, MScp.x.brodkapedro@mdx.ac.uk

Lygeri Dimitriou, Drl.dimitriou@mdx.ac.uk

How to Get in Touch

Patrycja Brodka Pedrp, MSc

Sponsor contact

CONTACT

020-8411-2721 p.x.brodkapedro@mdx.ac.uk

Lygeri Dimitriou, Dr

Sponsor contact

CONTACT

020-8411-4354 l.dimitriou@mdx.ac.uk

Data sourced from ClinicalTrials.gov · Last verified: 2025-06